CNVIF (Conavi Medical) Piotroski F-Score: N/A (As of Jul. 02, 2026)


CNVIF Conavi Medical Corp CNVIF
4 GF Score
Price $0.18
! 5 Warning Signs
View Full Analysis

What is Conavi Medical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Conavi Medical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Conavi Medical's Piotroski F-Score or its related term are showing as below:

Conavi Medical  (OTCPK:CNVIF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Conavi Medical Piotroski F-Score Related Terms


Conavi Medical Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Conavi Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conavi Medical Piotroski F-Score Chart

Conavi Medical Annual Data
Trend Sep24 Sep25
Piotroski F-Score
N/A N/A

Conavi Medical Quarterly Data
Sep23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only N/A N/A N/A N/A N/A

CNVIF vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Conavi Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conavi Medical Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conavi Medical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Conavi Medical's Piotroski F-Score falls into.


CNVIF
4GF Score
Conavi Medical Corp CNVIF
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -2.605 + -4.912 + -1.961 + -3.49 = $-12.97 Mil.
Cash Flow from Operations was -5.675 + -3.599 + -3.074 + -4.89 = $-17.24 Mil.
Revenue was 0.046 + 0.265 + 0.158 + 0.095 = $0.56 Mil.
Gross Profit was 0.045 + 0.241 + 0.158 + 0.095 = $0.54 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(4.748 + 12.945 + 8.995 + 7.132 + 10.432) / 5 = $8.8504 Mil.
Total Assets at the begining of this year (Mar25) was $4.75 Mil.
Long-Term Debt & Capital Lease Obligation was $12.33 Mil.
Total Current Assets was $7.52 Mil.
Total Current Liabilities was $5.37 Mil.
Net Income was -9.506 + -1.818 + -4.938 + -2.177 = $-18.44 Mil.

Revenue was 0.293 + 0 + 6.06 + 0.04 = $6.39 Mil.
Gross Profit was -0.042 + 0.027 + 4.974 + 0.101 = $5.06 Mil.
Average Total Assets from the begining of last year (Sep23)
to the end of last year (Mar25) was
(0 + 0 + 6.32 + 8.119 + 4.748) / 5 = $6.39566667 Mil.
Total Assets at the begining of last year (Sep23) was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $13.22 Mil.
Total Current Assets was $1.62 Mil.
Total Current Liabilities was $6.92 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Conavi Medical's current Net Income (TTM) was -12.97. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Conavi Medical's current Cash Flow from Operations (TTM) was -17.24. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-12.968/4.748
=-2.73125527

ROA (Last Year)=Net Income/Total Assets (Sep23)
=-18.439/0
=

Conavi Medical's return on assets of this year was -2.73125527. Conavi Medical's return on assets of last year was . ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Conavi Medical's current Net Income (TTM) was -12.97. Conavi Medical's current Cash Flow from Operations (TTM) was -17.24. ==> -17.24 <= -12.97 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=12.327/8.8504
=1.3928184

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Mar25
=13.222/6.39566667
=2.06733726

Conavi Medical's gearing of this year was 1.3928184. Conavi Medical's gearing of last year was 2.06733726. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=7.52/5.374
=1.39933011

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1.616/6.917
=0.2336273

Conavi Medical's current ratio of this year was 1.39933011. Conavi Medical's current ratio of last year was 0.2336273. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Conavi Medical's number of shares in issue this year was 99.89. Conavi Medical's number of shares in issue last year was 44.25. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.539/0.564
=0.95567376

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5.06/6.393
=0.79149069

Conavi Medical's gross margin of this year was 0.95567376. Conavi Medical's gross margin of last year was 0.79149069. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=0.564/4.748
=0.11878686

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep23)
=6.393/0
=

Conavi Medical's asset turnover of this year was 0.11878686. Conavi Medical's asset turnover of last year was . ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+1+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Conavi Medical has an F-score of 5 indicating the company's financial situation is typical for a stable company.


Conavi Medical Business Description

Other Exchanges CNVI:Canada
Address 293 Lesmill Road, Toronto, ON, CAN, M3B 2V1
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
4GF Score

Get the complete analysis for CNVIF

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price